EUR: statistics and indicators

74 indicators and 1,870 data points for EUR, collected automatically from official statistical sources.

Indicators
74
Data points
1,870

Browse EUR data by subject

Key indicators for EUR

IndicatorLatest YearRank Trend
Total tetanus - number of reported cases 85 2025 16th volatile
Pertussis - number of reported cases 52,021 2025 6th volatile
Infant mortality rate (probability of dying between birth and age 1) 6.52 2024 15th falling
Under-five mortality rate 7.7 2024 15th volatile
Maternal mortality ratio 11.16 2023 12th falling
Number of deaths among children ages 5 to 9 years 8,827 2024 15th falling
Mortality rate among children ages 5 to 9 years 0.7826 2024 15th falling
Number of deaths among adolescents 10,454 2024 16th falling
Proportion of population with primary reliance on polluting fuels and 7.6% 2023 12th falling
Population with primary reliance on polluting fuels and technologies 18.78 2023 12th falling
Population with primary reliance on clean fuels and technologies for 229.11 2023 6th flat
Women who have their need for family planning satisfied with modern 75.5% 2025 7th rising
Proportion of population with primary reliance on fuels and 16.8% 2023 12th falling
Population with primary reliance on fuels and technologies for 14.95 2023 12th falling
Prevalence of diabetes, age-standardized 8.68 2022 16th rising
Prevalence of diabetes, crude 11.52 2022 10th rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage 92.0% 2025 4th flat
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 94.0% 2025 3rd flat
Diphtheria tetanus toxoid and pertussis third-dose  (DTP3) 91.0% 2025 3rd flat
New HIV infections 0.16 2025 3rd rising
BCG immunization coverage among 1-year-olds (%) 94.0% 2025 2nd flat
Mean total cholesterol, age-standardized 4.9 2018 1st falling
Mean HDL cholesterol, crude 1.4 2018 1st flat
Mean total cholesterol, crude 5 2018 1st falling
Stunting numbers among children under 5 years of age (millions) 2,305 2024 18th falling
Stunting prevalence among children under 5 years of age (%) 4.6% 2024 17th falling
Overweight prevalence among children under 5 years of age (%) 7.5% 2024 7th falling
Overweight numbers among children under 5 years of age (thousands) 3,812 2024 18th falling
Adolescent mortality rate 0.7731 2021 12th falling
Incidence of tuberculosis 22 2024 15th falling
Deaths due to tuberculosis among HIV-negative people 1.6 2024 15th volatile
Number of women of reproductive age (aged 15-49 years) with anaemia 43,358 2023 18th rising
Domestic private health expenditure (PVT-D) as percentage of current 33.0% 2023 13th falling
Prevalence of HIV among adults aged 15 to 49 0.5% 2025 4th rising
Estimated number of people (all ages) living with HIV 3.10 million 2025 8th rising
Estimated antiretroviral therapy coverage among people living with HIV 67.0% 2025 8th rising
Hypertension treatment coverage among adults aged 30-79 with 56.2% 2019 4th rising
Hypertension among adults aged 30-79 years, prevalence 36.9 2019 2nd falling
Hypertension: effective treatment coverage (controlled hypertension) 27.3% 2019 4th volatile
Hypertension: diagnosis coverage among adults aged 30-79 with 66.1% 2019 4th rising
Hypertension among adults aged 30-79 years, prevalence, crude 41.6 2019 1st falling
Hypertension: diagnosis coverage among adults aged 30-79 with 68.7% 2019 4th rising
Number of new HIV infections 150,000 2025 6th rising
Births attended by skilled health personnel 99.1% 2025 1st flat
Number of current of tobacco users, estimate 160.43 million 2030 6th falling
Estimate of current tobacco use prevalence (%) 22.3% 2030 1st falling
Number of current tobacco smokers, estimate 156.74 million 2030 4th falling
Inactivated first-dose polio vaccine (IPV1) immunization coverage 94.0% 2025 2nd rising
Low birth weight number 796 2020 18th flat
Concentrations of fine particulate matter 10.53 2023 17th falling
Estimated number of MDR/RR-TB incident cases 55,000 2024 8th falling
Number of children aged 6-59 months with anaemia 11,457 2019 15th falling
Prevalence of anaemia in pregnant women (aged 15-49) 14.8% 2019 7th flat
Mean hemoglobin level of children aged 6-59 months 119 2019 5th flat
Prevalence of anaemia in non-pregnant women (aged 15-49) 12.3% 2019 8th rising
Mean hemoglobin level of women of reproductive age 129 2019 5th flat
Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 10th flat
Mean hemoglobin level of non-pregnant women 129 2019 5th flat
Prevalence of anaemia in children aged 6-59 months 20.3% 2019 11th falling
Number of deaths attributed to non-communicable diseases, by type of 2.09 million 2019 6th rising
Estimated number of malaria cases 0 2024 12th volatile
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 4th flat
Estimated number of children needing antiretroviral therapy based on 19,000 2025 12th rising
Estimated antiretroviral therapy coverage among children 84 2025 1st volatile
HPV immunization coverage estimates among primary target cohort (9-14) 46.0% 2025 4th rising
Smear-positive tuberculosis treatment-success rate 66.0% 2011 14th flat
Number of indigenous P. falciparum malaria cases 0 2020 12th flat
Number of suspected malaria cases 861,048 2020 12th falling
Number of malaria positive cases by microscopy 144 2020 12th falling
Number of malaria suspects examined by microscopy 857,130 2020 12th falling
Percentage of people living with HIV who have suppressed viral loads 61 2025 10th rising
Percentage of people living with HIV receiving treatment who have 91 2025 10th rising
Number of imported malaria cases 142 2020 12th falling
Women of reproductive age (aged 15-49 years) who have their need for 77.8% 2024 5th rising

Share, cite or embed this page

Cite this page

EUR: statistics and indicators. Statizoid, drawing on Statizoid. Retrieved 26 September 2026, from https://statizoid.com/place/eur/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under the original publishers' licences; please keep the attribution.

<a href="https://statizoid.com/place/eur/">EUR: statistics and indicators</a> — Statizoid